Haemophilia registries to complement clinical trial data: a pious hope or an urgent necessity?-Reference-Cited by-同舟云学术

Haemophilia registries to complement clinical trial data: a pious hope or an urgent necessity?

Published:2016-07-11 Issue:5 Volume:22 Page:647-650
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Keipert C.¹,van den Berg H. M.²,Keller-Stanislawski B.³,Hilger A.¹

Affiliation:

1. Hematology and Transfusion Medicine; Paul-Ehrlich-Institut; Langen Germany

2. University Medical Center Utrecht; Utrecht The Netherlands

3. Safety of Medicinal Products and Medical Devices; Paul-Ehrlich-Institut; Langen Germany

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13015/fullpdf

Reference15 articles.

1. The importance and challenge of pediatric trials of hemophilia drugs;Huff;Nat Med,2014

2. Regulation (EC) No 1901/2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004;The European Parliament and the Council;Official J Eur Union,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies;Haemophilia;2019-05

2. Clinical trials and registries in haemophilia: Opponents or collaborators? Comparison of PUP data derived from different data sources;Haemophilia;2018-02-13

3. Congenital bleeding disorders: Report from one tertiary centre in Guatemala;Haemophilia;2018-01-30

4. The current state of adverse event reporting in hemophilia;Expert Review of Hematology;2016-12-26